Conte Edoardo, Carbucicchio Corrado, Catto Valentina, Kochi Adriano Nunes, Mushtaq Saima, De Iuliis Pasquale Giovanni, Guglielmo Marco, Baggiano Andrea, Sattin Tommaso, Pontone Gianluca, Pepi Mauro, Tondo Claudio, Andreini Daniele
Centro Cardiologico Monzino, IRCCS, Milan, Italy; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Centro Cardiologico Monzino, IRCCS, Milan, Italy.
J Cardiovasc Comput Tomogr. 2022 May-Jun;16(3):262-265. doi: 10.1016/j.jcct.2021.12.003. Epub 2021 Dec 22.
Aim of the present study was to verify the feasibility and accuracy of live integration of myocardial fibrosis evaluated at CCT with EAM (electro-anatomical mapping).
We prospectively enrolled a consecutive cohort of patients with clinical indication to EAM before radiofrequency catheter ablation (RFCA) of refractory ventricular tachycardia (VT) and an absolute contraindication to cardiac magnetic resonance. All patients underwent per protocol CCT for myocardial fibrosis and coronary anatomy evaluation. Diagnostic performance was assessed for myocardial fibrosis evaluation with CCT vs EAM. Live integration feasibility of CCT vs EAM was evaluated for every patients.
A total of 19 patients were included in the present study with 323 myocardial segments analyzed for myocardial fibrosis at CCT. In all patients CCT data were successfully integrated with EAM during RFCA procedure. All patients had myocardial fibrosis correctly identified at CCT vs EAM on a per-patients basis. A diagnostic accuracy on a per-segment basis of 94.1% for detection of any type of myocardial fibrosis at CCT vs EAM was recorded.
CCT identification of myocardial fibrosis is feasible and accurate vs EAM in a very selected high risk patients with clinical indication to RFCA of VT and contraindication to CMR.
